Dr. Ranjit Bindra's lab at Yale University focuses on understanding and treating acute myeloid leukemia (AML), particularly in patients with mutations in genes called IDH1 and IDH2. These mutations disrupt important DNA repair processes, making cancer cells vulnerable to specific therapies. The lab is investigating new ways to combine existing drugs to enhance treatment effectiveness, especially for patients who have not responded well to current therapies.

Dr. Luisa Escobar Hoyos's lab at Yale University focuses on uncovering new ways to enhance the immune response against cancers, particularly through T-cell activation. Research efforts aim to understand how RNA splicing defects influence T-cell function and how targeting these defects can improve cancer immunotherapy. The lab also studies the implications of specific mutations in pancreatic cancer, aiming to develop therapies that correct these mutations to better combat aggressive tumor growth.

Dr. Henk De Feyter's lab at Yale University focuses on advancing brain tumor imaging techniques, particularly for glioblastoma, which is a common and aggressive type of brain cancer. They are innovating a new MRI-based method called Deuterium Metabolic Imaging (DMI) to detect abnormal glucose metabolism in brain tumors, providing a non-invasive way to monitor tumor progression and treatment response. This research aims to improve diagnosis and treatment strategies for patients with brain tumors by offering a more reliable imaging option compared to traditional methods.

Dr. James S. Duncan's lab at Yale University focuses on improving treatments for autism spectrum disorder (ASD) and liver cancer using advanced imaging techniques and machine learning. For autism, the team aims to develop deep learning models that can identify brain biomarkers and predict treatment outcomes. In liver cancer, they explore innovative imaging methods to characterize tumor environments and improve patient care through personalized treatment strategies based on non-invasive biomarkers.

Dr. Michelle Hampson's lab at Yale University focuses on innovative treatments for adolescents with Tourette Syndrome using neurofeedback techniques. Their current research is a clinical trial that helps participants learn to control specific areas of their brain to reduce tic severity through targeted mental strategies. The lab aims to confirm the effectiveness of this intervention and analyze its impact on brain connectivity and behavior.

Dr. Yiyun Henry Huang's lab at Yale University focuses on understanding and diagnosing Alzheimer's disease using advanced imaging techniques. The lab is particularly interested in the sigma-1 receptor, which plays a crucial role in the disease's progression. By developing new PET imaging agents, the lab aims to uncover important biomarkers that could lead to earlier diagnosis and better monitoring of disease treatments.

Dr. Georges El Fakhri's lab at Yale University focuses on advancing imaging technologies in healthcare, particularly using PET (Positron Emission Tomography) for improved diagnosis and treatment of diseases like cancer and Alzheimer's. The lab’s research includes developing new PET scanner designs, enhancing methods for quantifying tau protein in the brain associated with Alzheimer's, and using deep learning to personalize treatment plans for prostate cancer patients receiving radionuclide therapy. Their work aims to improve patient outcomes through better imaging and treatment strategies.

Dr. Chao Ma's lab focuses on enhancing the treatment of gliomas, a common type of malignant brain tumor, through advanced imaging techniques. They are developing a novel imaging technology that combines Magnetic Resonance Spectroscopic Imaging (MRSI) with machine learning to achieve high-resolution metabolic images of tumors. This research aims to improve the accuracy of radiation therapy planning by precisely mapping tumor boundaries, which is crucial for better patient outcomes in glioma treatment.

Dr. Graeme F. Mason's lab at Yale University studies how alcohol affects brain metabolism, particularly the role of acetate, a byproduct of alcohol, in energy use and stress responses. The research aims to understand how acetate influences brain structure and behavior in individuals who drink alcohol, including heavy and dependent drinkers. The lab also explores potential therapeutic interventions for alcohol dependence, focusing on metabolic adaptations and brain health.

Dr. Richard E. Carson's lab focuses on developing innovative radioligands for positron emission tomography (PET) to advance our understanding of mental health disorders. They explore the role of various molecular targets, such as receptors and transporters in the brain, that are implicated in conditions like depression and schizophrenia. By validating these radioligands, the lab aims to improve the diagnosis and treatment of mental health issues and contribute to the broader field of molecular neuroscience.

Dr. Evan D. Morris's lab at Yale University focuses on understanding how specific brain receptors affect behaviors associated with Alcohol Use Disorder (AUD). Through advanced imaging techniques and machine learning, the lab studies the imbalance between Mu and Kappa opioid receptors in the brain and how this impacts cravings and recovery outcomes for individuals trying to quit drinking. By identifying these relationships, the research aims to inform better treatment strategies for AUD.

Dr. R. Todd Constable's lab at Yale University is focused on advancing MRI technology and understanding the brain's functions and dysfunctions, particularly in relation to neuropsychiatric symptoms from infections like COVID-19. The lab works on making MRI more accessible through innovative low-cost systems, while also researching the brain circuits involved in cognitive and behavioral changes after illness. By merging neuroscience with advanced imaging techniques, they aim to develop better diagnostic and treatment strategies for patients with complex neurological disorders.

Dr. Zhengxin Cai's lab focuses on improving the understanding and management of spinal cord injuries (SCI) through advanced imaging techniques. The lab uses a special PET imaging technology to visualize changes in the brain and spinal cord, which may help in diagnosing and tracking the recovery of patients with SCI. Their goal is to provide new insights into neuroplasticity and therapeutic effects, ultimately enhancing patient care and therapy outcomes.

Dr. Chi Liu's lab at Yale University is focused on enhancing the accuracy and reliability of Positron Emission Tomography (PET) imaging through innovative deep learning techniques. By addressing the issue of high image noise in PET scans, the lab aims to develop software that transforms standard clinical images into high-quality outputs, ultimately improving clinical decision-making and patient outcomes. The lab collaborates with top academic centers and industry leaders to ensure that their advancements can be effectively integrated into clinical practice.

Dr. Dana C. Peters' lab focuses on improving cardiac MRI techniques to better diagnose heart failure, particularly heart failure with preserved ejection fraction (HFpEF), which is often challenging to identify with traditional methods. The lab is developing innovative MRI methods to measure diastolic function and the pressures in the heart that contribute to symptoms like unexplained breathlessness. Their research integrates advanced imaging techniques and deep learning to enhance the accuracy and reliability of cardiac evaluation, especially before and after exercise.

Dr. Peter Glazer's lab focuses on finding ways to treat cancer by targeting specific weaknesses in tumor DNA repair processes. They study how certain mutations can make tumors more vulnerable to treatments that exploit these weaknesses. The lab combines basic science research with clinical trials to develop innovative therapies, including unique antibody treatments and small molecule drug combinations, aimed at improving outcomes for cancer patients.

Dr. Jason Bini's research lab at Yale University focuses on understanding type 1 diabetes, particularly how it affects insulin production in the body. The lab uses advanced imaging techniques like PET and MRI to study changes in the pancreas, including how well insulin-producing cells are functioning. By tracking these changes over time, the lab aims to improve treatment strategies for individuals at risk or newly diagnosed with type 1 diabetes, ultimately enhancing their quality of life.